oxprenolol has been researched along with methyldopa in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (77.50) | 18.7374 |
1990's | 1 (2.50) | 18.2507 |
2000's | 2 (5.00) | 29.6817 |
2010's | 6 (15.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Barritt, DW; Marshall, AJ; Roberts, CJ | 1 |
Talbot, S | 1 |
Barritt, DW; Heaton, S; Marshall, AJ | 1 |
Condon, J; Jackson, G; Mahon, W; Pierscianowski, TA | 1 |
Backer, P; Gyntelberg, F; Jacobsen, K; Martlev, A | 1 |
Hansen, M; Hansen, OP; Lindholm, J | 1 |
Levenstein, JH | 2 |
Seedat, YK | 1 |
Gallery, ED; Györy, AZ; Hunyor, SN; Saunders, DM | 1 |
Gadd, RL; McFarlane, T; Nysenbaum, A | 1 |
Forrest, WA | 3 |
Beilin, LJ; Ledingham, JG; Thomas, GW; Yeates, KM | 1 |
McLaren, EH | 1 |
Freeman, JW; Knight, LW | 1 |
Herlitz, H | 1 |
Fogari, R; Zoppi, A | 1 |
Bulpitt, CJ; Fletcher, AE; Hill, JF | 1 |
Traub, YM | 1 |
Garrido Peralta, M; Gras, X; Ocón, J; Oliván, J; Rodicio, JL; Rodríguez Alvarez, J; Ruilope, L; Seco Vasco, J | 1 |
Gallery, ED; Gyory, AZ; Ross, MR | 1 |
Sandström, B | 1 |
Rubin, PC | 1 |
De Swiet, M; Fayers, P; Fidler, J; Smith, V | 1 |
Burke, T | 1 |
Barrow, CG; O'Halloran, MW; Wilson, LL; Zacest, R | 1 |
MacFadyen, EE; Scully, C; Wiesenfeld, D | 1 |
Benfield, GF; Hunter, KR | 1 |
Boyce, ES; Gallery, ED; Gyory, AZ; Hunyor, SN; Larkin, H | 1 |
2 review(s) available for oxprenolol and methyldopa
Article | Year |
---|---|
ACE-inhibitors and quality of life.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Enalapril; Health Status; Humans; Hypertension; Methyldopa; Middle Aged; Oxprenolol; Quality of Life | 1990 |
[Beta-blockers in the therapy of arterial hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Diuretics; Female; Humans; Hypertension; Methyldopa; Oxprenolol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol; Uterine Contraction | 1985 |
14 trial(s) available for oxprenolol and methyldopa
Article | Year |
---|---|
Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Female; Heart Rate; Humans; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Physical Exertion; Posture; Pulse | 1976 |
[2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
Topics: Adult; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Drug Evaluation; Drug Therapy, Combination; Economics, Medical; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Oxprenolol; Potassium Chloride; Sodium Chloride Symporter Inhibitors; Time Factors | 1977 |
Controlled clinical study on antihypertensive treatment with a diuretic and methyldopa compared with a beta-blocking agent and hydralazine.
Topics: Blood Pressure; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydralazine; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Physical Exertion; Sodium Chloride Symporter Inhibitors | 1977 |
Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Potassium Chloride; Pulse; Sodium Chloride Symporter Inhibitors | 1978 |
Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.
Topics: Adult; Birth Weight; Blood Glucose; Creatinine; Female; Humans; Hypertension; Methyldopa; Oxprenolol; Plasma Volume; Pregnancy; Pregnancy Complications, Cardiovascular; Random Allocation; Uric Acid | 1979 |
Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Furosemide; Humans; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Placebos; Posture; Renin; Spironolactone; Stimulation, Chemical | 1976 |
Angiotensin converting enzyme inhibitors and quality of life: the European trial.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Prospective Studies; Quality of Life; Random Allocation | 1985 |
Comparison of oxprenolol vs methyldopa as second-line antihypertensive agents in the elderly.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Diuretics; Female; Humans; Hypertension; Male; Methyldopa; Oxprenolol; Prospective Studies; Pulse; Random Allocation | 1988 |
[Multicenter study of the efficacy of 3 antihypertensive regimens: captopril + hydrochlorothiazide, oxprenolol + hydrochlorothiazide, and alphamethyldopa + hydrochlorothiazide].
Topics: Adult; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Prospective Studies; Spain | 1985 |
Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa.
Topics: Adult; Birth Weight; Clinical Trials as Topic; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Male; Methyldopa; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular; Random Allocation | 1985 |
Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy.
Topics: Adult; Birth Weight; Clinical Trials as Topic; Female; Gestational Age; Humans; Hypertension; Methyldopa; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular; Random Allocation | 1983 |
Relationship of psychological factors to failure of antihypertensive drug treatment.
Topics: Adult; Antihypertensive Agents; Bethanidine; Clonidine; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Patient Dropouts; Personality; Time Factors | 1981 |
Oxprenolol, methyldopa and lipids in diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Humans; Hypertension; Lipids; Male; Methyldopa; Middle Aged; Oxprenolol; Random Allocation | 1982 |
Cardiac and haemodynamic measurements in hypertensive pregnancy.
Topics: Adult; Cardiac Output; Echocardiography; Female; Heart; Heart Ventricles; Hemodynamics; Humans; Hypertension; Methyldopa; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular | 1980 |
24 other study(ies) available for oxprenolol and methyldopa
Article | Year |
---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Raynaud's phenomenon as side effect of beta-blockers in hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Propranolol; Raynaud Disease; Skin Temperature | 1976 |
Angina in hypertensive patients. With particular reference to the negative chronotropic effects of sympatholytic therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bethanidine; Blood Pressure; Debrisoquin; Drug Therapy, Combination; Guanethidine; Heart Rate; Humans; Hypertension; Male; Methyldopa; Oxprenolol; Physical Exertion; Propranolol; Sympatholytics | 1976 |
Inappropriate antihypertensive therapy in the elderly.
Topics: Age Factors; Aged; Antihypertensive Agents; Cyclopenthiazide; Drug Therapy, Combination; Humans; Hypertension; Hypotension, Orthostatic; Methyldopa; Middle Aged; Oxprenolol; Potassium Chloride | 1976 |
Oxprenolol plus cyclopenthiazide-KCl versus methyldopa in the treatment of hypertension.
Topics: Cyclopenthiazide; Diuretics; Humans; Hypertension; Methyldopa; Oxprenolol; Sodium Chloride Symporter Inhibitors | 1979 |
Oxprenolol plus cyclopenthiazide-kci versus methyldopa in the treatment of hypertension.
Topics: Cyclopenthiazide; Drug Evaluation; Hypertension; Methyldopa; Oxprenolol; Research Design | 1979 |
Fetal hazards of altering hypotensive regimens in pregnancy.
Topics: Adult; Female; Fetal Distress; Humans; Hypertension; Methyldopa; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy in Diabetics | 1979 |
Experience with sustained-release oxprenolol (slow trasicor) in the management of hypertension in general practice.
Topics: Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Patient Dropouts | 1979 |
Severe hypertension produced by interaction of phenylpropanolamine with methyldopa and oxprenolol.
Topics: Adult; Drug Interactions; Humans; Hypertension; Hypertension, Renal; Male; Methyldopa; Oxprenolol; Phenylpropanolamine | 1976 |
Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
Topics: Humans; Hypertension; Methyldopa; Oxprenolol; Pindolol; Posture; Propranolol; Renin; Spironolactone | 1976 |
Oxprenolol and hydrallazine in the treatment of hypertension.
Topics: Adult; Diuretics; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol | 1975 |
Oxprenolol in hypertension: a report on 2,770 patients in general practice originally treated with methyldopa.
Topics: Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Humans; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; United Kingdom | 1976 |
Proceedings: General practitioner studies of beta-blockade in hypertension.
Topics: Adrenergic beta-Antagonists; Benzothiadiazines; Cyclic S-Oxides; Cyclopentanes; Diuretics; Drug Synergism; Hypertension; Methyldopa; Oxprenolol; Potassium Chloride; Sodium Chloride Symporter Inhibitors | 1974 |
Clinical trials of adrenergic antagonists in pregnancy hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Apgar Score; Birth Weight; Female; Fetal Growth Retardation; Humans; Hydralazine; Hypertension; Infant, Newborn; Methyldopa; Metoprolol; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular; Respiratory Distress Syndrome, Newborn | 1984 |
Beta blockers in pregnancy.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Humans; Hypertension; Kinetics; Methyldopa; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular | 1984 |
Trasicor versus methyldopa in Pakistani hypertensive patients: a comparative study of efficacy and tolerability.
Topics: Chlorthalidone; Drug Therapy, Combination; Humans; Hypertension; Methyldopa; Oxprenolol; Pakistan | 1981 |
Multiple lichenoid drug reactions in a patient with Ferguson-Smith disease.
Topics: Carcinoma, Squamous Cell; Female; Humans; Lichen Planus; Methyldopa; Middle Aged; Mouth Diseases; Neoplasms, Multiple Primary; Oxprenolol; Skin Neoplasms | 1982 |